Power

3D printing finally found its market, and all it took was a pandemic

When COVID-19 disrupted supply chains, 3D printing stepped in to fill the gap. Will it stick around once the dust has settled?

Masks

An example of an FFP3 mask developed by research institute CIIRC CVUT and printed with HP Multi Jet Fusion 3D-printing technology.

Photo: Courtesy of HP

When the spread of COVID-19 decimated supply chains around the world, countries scrambled for important medical supplies — face masks, swabs, ventilators, drugs — but found few places to source them. In response, a global groundswell of companies and hobbyist makers rushed to fill the gap any way they could. For many, that meant 3D printing. Fast-forward six weeks, and tens of thousands of parts have been printed, helping to save lives and protect frontline workers.

3D printing has long been hyped as the harbinger of an industrial revolution. With a small machine and a bit of patience, anyone would be able print anything from the comfort of a couch. The technology carries some benefits over traditional manufacturing techniques: Prototyping is quicker, customizing is easier, and machines can be set up almost anywhere, meaning you can produce a lot closer to where the products need to go. But reality has set in as well: 3D printing is slow, expensive and only really works well for a few materials.

The pandemic has illuminated these opportunities and obstacles, showing businesses that there's value in building the kinds of distributed supply chains that 3D printing promises — but also that what works for some products won't apply to others. When the dust settles, the question will be whether the technology gets relegated back to the outer fringes of trade shows or becomes a more integral part of the way the world makes things.

"Certainly, supply chains broke in the midst of all this, and 3D printing is now one of the solutions for those gaps," Michael Shanler, an analyst at Gartner, told Protocol. "Unfortunately we were waiting for an event like this for that to be proven."

What's happening right now

Some of the largest 3D-printing companies have stepped up to help plug gaps that coronavirus opened in the supply chain, especially for protective equipment for health care workers. HP spun up a COVID-19 task force, mobilizing a global effort to design and manufacture products that could be printed on its industrial-size machines. The team, led by Fabio Annunziata, HP's 3D printing strategic alliances head, brought together hundreds of employees across the company in a few days to start sourcing designs and working with customers, as well as HP's own resources, to print parts.

HP has printed and shipped over 50,000 items. With its partners and clients, that number jumps to 1.5 million 3D-printed parts for ventilators, CPAP respirators, face shields, masks and other devices. The company put all of the vetted designs on its website for anyone to download and print.

Companies like SmileDirectClub, which produces 3D-printed invisible braces, used their printers to ship over 35,000 face shields in a matter of weeks. Avid, a product development company, came up with its own design for a face shield, and founder Doug Collins told Protocol the design is now up on HP's site. Six weeks ago, Collins pulled everyone on his team off customer projects to come up with a simple design that would cover the top of doctors' heads to prevent infection when they lean in to inspect a patient. They sketched up the design, made prints to perfect it, and started working with HP to release it. Like many other projects around the world, it can now be found in the U.S. National Institutes for Health's growing repository of 3D-printing files for COVID-19.

Other groups, such as the My Mask Movement, backed by Stanley Black & Decker, leaped into action to make use of 3D printing's ability to personalize products without having to retool any machinery. The nonprofit built an app that uses the depth-sensing cameras in newer iPhones to scan a person's face and build a 3D model that fits them perfectly. The mask design has been approved for clinical use by the NIH. Project leader Jesse Chang told Protocol that the precision of the industrial printers used to produce these masks was "completely unfathomable" five years ago. For doctors on the front lines, that level of accuracy could make the difference between contracting the virus and blocking it. "Getting down to that level of precision isn't just nice, it's necessary," Chang said.

What companies have learned

HP can see where it's designs are being printed across the world. Although Annunziata's task force ramped up when Italy and Spain began to get ravaged by the virus, the majority of the printing has since shifted to the U.S., the current epicenter of the pandemic. The company is now focusing on trying to fill the latest hole in the supply chain: nasal swabs, a key tool in the nasopharyngeal COVID-19 tests. One of the benefits of 3D printing is that an object made of one material can have multiple physical properties, Annunziata said. The swabs HP has developed, made entirely of plastic, are rigid at the end the health care worker holds, and pliable at the end that has to go into a patient's nose.

3D printed swabs HP's 3D printed nasopharyngeal swabs, all made of one material.Photo: Courtesy of HP

Annunziata highlighted the speed that 3D printing afforded members of his team, explaining that they can retool manufacturing capacity in a matter of hours so they aren't "hostage to the traditional supply chain." HP has a supply of the powder it uses to print products and is working with European governments to ensure it can continue to meet demand. Governments around the world, including Spain and the U.S., Annunziata added, have lowered regulatory hurdles to ensure products can get reviewed and approved for medical use as quickly as possible. But given the repetitive precision that 3D printing allows, the products can still be high quality. Clara Remacha Corbalán, who works in medical market development for HP, said one of the company's face mask designs was awarded a CE mark, meaning it hit safety standards and can be sold in the E.U. even after the pandemic subsides. "I do hope that it's going to be a tipping point for this industry," Annunziata said.

Chang said his team realized how quickly the organization had to move, primarily because there were no other options for many frontline workers, no slack capacity in existing supply chains. "The reason why we need to exist is because there's just not enough masks out there," Chang said. "There are no magical factories out there."

It's not a panacea

For some in the 3D-printing industry, though, the technology can only solve some manufacturing hurdles. Stratasys, one of the oldest 3D-printing companies, has been using its resources to deliver face shields, splitters for ventilators and other ventilator parts. But after iterating and settling on a design, manufacturing at scale is still an issue. Scott Drikakis, health care segment leader at Stratasys, said that one of the company's hobbyist-level MakerBot printers can make one visor for a face shield in about two hours, while one of its industrial-size Fortus machines can produce about 40 in five to six hours. With nasal swabs, it's different: A large printer can make around 1,500 in about six hours. The smaller the project, the more useful a single printer can be, but that hints at a flaw in 3D printing as a manufacturing method.

Once Stratasys validated its design for face shields, Drikakis said, it actually bought equipment to produce them at scale with injection molding, rather than 3D printers. "In the first three days, we had over 300,000 requests for face shields, and we said there's no way 3D printing is going to solve this, but it could be a bridge while we ordered the tooling," he said.

"It's a lot easier for a government to organize truckloads or plane loads of equipment and materials to get shipped around the world than setting up and scaling a 3D-printing operation," Gartner's Shanler said.

On the other hand, 3D printing can provide millions of nasal swabs each week, which could help ensure the U.S. has the testing capacity to consider opening the country back up. "The government said that there was this supply gap, and the 3D-printing industry has been able to meet that demand," Drikakis said. "And you're not talking about tens or hundreds; we're talking millions."

What might stick around

Unless 3D-printing technologies continue to progress to the point where they can compete with traditional manufacturing techniques on price, it seems unlikely they will usurp the status quo once supply chains are reestablished. Still, 3D printing could play a greater role in the manufacturing ecosystem moving forward, experts agree.

Personalizing products is a difficult task for traditional manufacturing, but for smaller-batch, higher-value items — like medical equipment — 3D printing could make a lot of sense even after the pandemic recedes. "The vast majority of doctors are focused on their work, and I'm not so sure they knew how much 3D printing could be unleashed into their industry," said Stanley Liu, a professor at Stanford University and a head and neck surgeon at the university's medical center, who has been working on the My Mask Movement. Liu said he now uses 3D printing to help plan surgeries, but sees many opportunities for personalization of equipment to better fit people wearing it. "All of us have been wearing masks that don't fit — this sort of slipped everybody's mind until now," he said.

And whether there's a second wave of COVID-19, or another pandemic takes hold of the world in the future, greater investment in 3D printing can help plug the gaps if supply chains break down again. "The technology's proven," Shanler said. "It's hitting that little spot for helping meet some surge capacity and doing on-demand print behaviors."


Get in touch with us: Share information securely with Protocol via encrypted Signal or WhatsApp message, at 415-214-4715 or through our anonymous SecureDrop.


"Historically, I think 3D printing has kind of been niched into engineering departments," Stratasys' Drikakis said. "Now — because there's been an increase in awareness — people are going to be in a position to say, 'How can we be more prepared for when this happens again?'"

3D printing and other automated forms of production could also figure in the debate over offshoring, helping companies make products in the U.S. in our new, more socially distant future. Chang refers to this idea as "Digitally 'Made in America.'" The country is facing the specter of the worst recession in generations, and supply chains in China are still scaling back up, so any ability to efficiently produce closer to demand will be valuable, Chang argues. "This is about freedom," he said, "and creating options."

Protocol | Fintech

A lawsuit tests who controls the stock market

Citadel Securities seeks to block IEX's product that limits high-frequency trading advantages.

Kenneth Griffin is the founder and chief executive officer of Citadel LLC, which argued during Monday's hearing that IEX's D-Limit order type shouldn't have been approved by the SEC.

Photo: Patrick T. Fallon/Bloomberg via Getty Images

Market maker Citadel Securities, stock exchange IEX and the Securities and Exchange Commission each gave oral arguments Monday in a legal case that could have large implications for financial markets.

Last October, Citadel Securities sued the SEC, seeking to reverse the SEC's previous decision last August to approve IEX's D-Limit order type, arguing that this order type would hurt the overall market. The case was argued before the U.S. Court of Appeals Monday.

Keep Reading Show less
Tomio Geron

Tomio Geron ( @tomiogeron) is a San Francisco-based reporter covering fintech. He was previously a reporter and editor at The Wall Street Journal, covering venture capital and startups. Before that, he worked as a staff writer at Forbes, covering social media and venture capital, and also edited the Midas List of top tech investors. He has also worked at newspapers covering crime, courts, health and other topics. He can be reached at tgeron@protocol.com or tgeron@protonmail.com.

If you've ever tried to pick up a new fitness routine like running, chances are you may have fallen into the "motivation vs. habit" trap once or twice. You go for a run when the sun is shining, only to quickly fall off the wagon when the weather turns sour.

Similarly, for many businesses, 2020 acted as the storm cloud that disrupted their plans for innovation. With leaders busy grappling with the pandemic, innovation frequently got pushed to the backburner. In fact, according to McKinsey, the majority of organizations shifted their focus mainly to maintaining business continuity throughout the pandemic.

Keep Reading Show less
Gaurav Kataria
Group Product Manager, Trello at Atlassian

Everything you need to know about the Allbirds IPO

Allbirds wants to become an iconic global brand for shoes and everything else.

Photo: Spencer Platt/Getty Images

The humble venture capitalist puts on her Allbirds one shoe at a time, just like everybody else (or at least everyone else in Palo Alto).

Since its founding in 2015, Allbirds has become an essential component of the tech bro uniform, alongside such staples as the embroidered Patagonia quarter-zip, Lululemon ABC pants, the Zuck-inspired black T-shirt and a Y Combinator-branded Hydro Flask.

Keep Reading Show less
Hirsh Chitkara
Hirsh Chitkara (@ChitkaraHirsh) is a researcher at Protocol, based out of New York City. Before joining Protocol, he worked for Business Insider Intelligence, where he wrote about Big Tech, telecoms, workplace privacy, smart cities, and geopolitics. He also worked on the Strategy & Analytics team at the Cleveland Indians.
Protocol | Policy

It’s Frances Haugen’s world. We’re all just living in it.

With the release of the Facebook Papers, Haugen holds Facebook's future in her hands.

Haugen's decision to open the trove of documents up to outlets beyond the Journal has sparked a feeding frenzy.

Photo: Frances Haugen

Facebook knows a thing or two about optimizing content for outrage. As it turns out, so does Frances Haugen.

Or at least, the heavyweight team of media and political operatives helping manage the rollout of her massive trove of internal documents seems to have learned the lesson well. Because the document dump known as the Facebook Papers, published the same day as Facebook's earnings call with investors and the same week as the conference where it plans to lay out its future as a metaverse company, wasn't just designed for mass awareness.

Keep Reading Show less
Issie Lapowsky

Issie Lapowsky ( @issielapowsky) is Protocol's chief correspondent, covering the intersection of technology, politics, and national affairs. She also oversees Protocol's fellowship program. Previously, she was a senior writer at Wired, where she covered the 2016 election and the Facebook beat in its aftermath. Prior to that, Issie worked as a staff writer for Inc. magazine, writing about small business and entrepreneurship. She has also worked as an on-air contributor for CBS News and taught a graduate-level course at New York University's Center for Publishing on how tech giants have affected publishing.

Here are all the Facebook Papers stories

They paint a picture of Facebook that's very different from what Mark Zuckerberg likes to say.

Image: Getty Images, Protocol

Monday morning's news drop was a doozy. There was story after story about the goings-on inside Facebook, thanks to thousands of leaked documents from Frances Haugen, the whistleblower who wants the information within those files to spread far and wide. Haugen is also set to speak in front of the British Parliament on Monday, continuing the story that is becoming known as The Facebook Papers.

Keep Reading Show less
David Pierce

David Pierce ( @pierce) is Protocol's editorial director. Prior to joining Protocol, he was a columnist at The Wall Street Journal, a senior writer with Wired, and deputy editor at The Verge. He owns all the phones.

Latest Stories